Common questions about Citao (FAQ)
Q: How long does it usually take to notice any effects from Citao?
A: Official information indicates that a patient may need to take Escitalopram for a month or longer before beginning to feel better. Improvement in physical symptoms, such as changes in sleep, energy, or appetite, may be seen within the first one to two weeks. However, improvements in mood may take up to six to eight weeks to fully develop.
Q: Can Citao cause tiredness during the day?
A: Yes, sleepiness or unusual drowsiness, also known as somnolence, is listed in regulatory documents as a common adverse reaction. Due to this potential effect, the official medication guide describes that patients should not drive or operate heavy machinery until they know how the drug affects them.
Q: Is Citao known to cause weight gain or weight loss?
A: Regulatory findings cite weight gain as a reported adverse event in clinical studies. The official documents describe the findings from these studies, but an individual's experience may vary and is not guaranteed.
Q: Do I need to get blood tests while I am taking Citao?
A: Official warnings note a risk of hyponatremia (low sodium levels in the blood), especially in older adults. For patients with certain pre-existing conditions, such as liver impairment, or known differences in how the medicine is processed, higher exposure is expected. Monitoring requirements, such as blood tests, are conditional and depend on an individual's health status.
Q: What is the maximum duration of treatment with Citao described in official sources?
A: Official documentation indicates that treatment for some conditions may require 'several months or longer of sustained pharmacological therapy.' The long-term usefulness of the medicine is subject to periodic re-evaluation. For some anxiety conditions, the efficacy beyond eight weeks has not been systematically studied in clinical trials.
Q: How does Citao affect sleep patterns?
A: Official documents list trouble sleeping (insomnia) and sleepiness/unusual drowsiness as common side effects of Citao. Changes in sleep habits are also cited as a potential symptom that can occur if the medication is stopped, which is known as discontinuation syndrome.
Q: Is Citao considered safe to use during pregnancy according to regulatory bodies?
A: Official guidance states that use during pregnancy is conditional and based on the potential benefit justifying the risk to the fetus. Use in the late stages of pregnancy has been associated with potential risks of bleeding after delivery and possible short-term withdrawal symptoms in the newborn, who would be monitored after birth.
Q: Is there any research on Citao use during breastfeeding?
A: Research indicates that Escitalopram passes into breast milk in low amounts. While it is generally not expected to cause adverse effects, reports of minor behavioral problems in breastfed infants, such as irritability or restlessness, have been noted in official databases. Official sources note that observation of the infant for signs such as irritability or restlessness is standard procedure.
Q: Does Citao cause stomach problems like nausea or digestive upset?
A: Yes, regulatory documents indicate that Nausea is classified as a very common side effect (occurring in 1 in 10 patients or more). Other common gastrointestinal effects that may cause digestive upset include dry mouth and diarrhea.
Q: Is Citao commonly used in combination with other similar medications?
A: Official warnings strictly prohibit the co-administration of Citao with Monoamine Oxidase Inhibitors (MAOIs) due to the risk of Serotonin Syndrome. Caution is also strongly advised when co-administering with other serotonergic agents (drugs that affect serotonin levels), as this also increases the risk of this serious condition.
Q: What is the evidence regarding Citao and long-term use?
A: Systematic evaluation has demonstrated a benefit of maintenance treatment for Major Depressive Disorder, and the drug is indicated for sustained use. For long-term use, the patient's condition and treatment needs are periodically re-evaluated, and older adults are monitored for risks like low sodium levels and abnormal bleeding.
Q: Does Citao affect blood pressure?
A: Official warnings require monitoring for cardiovascular effects, specifically mentioning the risk of QT interval prolongation which can lead to ventricular arrhythmias. However, changes in blood pressure (high or low) are not listed as a common or very common side effect in primary regulatory summaries.
Q: Is Citao the same kind of drug as similar medicines I've heard of?
A: Citao (Escitalopram) is classified as a Selective Serotonin Reuptake Inhibitor (SSRI). This category includes several common antidepressant and anti-anxiety medicines. Citao is specifically noted in regulatory documents as the purified (S)-enantiomer of Citalopram, meaning it is a refined version of an older, similar drug.
Q: What is the difference between the brand name and generic versions of Citao?
A: Generic versions of Citao (Escitalopram) are required by regulatory agencies like the FDA to be bioequivalent to the brand-name product. This means they must contain the same active ingredient and work in the same way, providing the same clinical benefit. Differences may exist in the inactive ingredients, such as fillers or binders.
Q: Will Citao change the way I feel emotionally?
A: The general purpose of the drug is to help restore neurochemical balance to support mood regulation. However, when first starting Citao, initial side effects can include feeling agitated, restless, or experiencing anxiety. These feelings are often temporary and tend to lessen as treatment continues.
Q: What should someone do if they forget to take a dose of Citao?
A: If a dose of Citao is missed, official instructions state that the individual should skip the missed dose entirely. They should then take the next dose at the regularly scheduled time and should not take two doses at once to make up for the one they missed.
Q: Are the side effects of Citao permanent?
A: Many common side effects, such as headache, nausea, and fatigue, are considered temporary. Official documents note that these symptoms often improve or resolve over the first week or two as the body adjusts to the medication. The label does not indicate that the vast majority of common side effects are permanent.
Q: Is Citao approved for use in children or adolescents?
A: Citao (Escitalopram) is approved by the FDA for the treatment of Major Depressive Disorder (MDD) in adolescents aged 12 to 17 years. It is not approved for use in patients under 12 years of age for any official indication.
Q: Are there official warnings about driving or operating machinery while on Citao?
A: Yes, official warnings advise that Citao may cause sleepiness or affect a person's ability to think clearly and react quickly. Official warnings describe that patients should not drive or operate heavy machinery until they understand the medication's effect on their ability to think clearly and react quickly.
Q: Is there a risk of dependency or addiction with Citao?
A: Citao is an SSRI and is not listed as a controlled substance under the U.S. Controlled Substances Act, nor is it classified as habit-forming. However, abruptly stopping treatment can cause withdrawal-like symptoms, which is why a gradual reduction in dose is recommended by regulatory agencies.
Q: Can Citao make existing anxiety worse initially?
A: Anxiety and restlessness are listed as potential side effects of Citao in official documents. It is noted that these symptoms may be more pronounced at the beginning of treatment or following a dose adjustment.
Q: Does Citao affect the effectiveness of birth control pills?
A: Clinical pharmacology studies do not show a direct interaction between Escitalopram and hormonal contraceptives that would alter the drug concentrations of either medicine. Regulatory information advises that all co-administered medications should be reviewed.
Q: Is Citao a controlled substance?
A: No. Escitalopram (Citao) is not listed as a controlled substance under the U.S. Controlled Substances Act. It is a prescription-only medication.
Q: What is the typical time frame for the initial side effects of Citao to lessen?
A: Common side effects like headache, nausea, and fatigue often improve or resolve over the first week or two. Official documents state that these symptoms generally lessen in severity as the body adjusts to the medication.
Q: Does Citao affect vision?
A: Yes. Official documents advise that Citao may cause or contribute to a serious eye condition called angle-closure glaucoma. Symptoms can include sudden changes in vision, eye pain, swelling, or redness in or around the eye.
Q: Is Citao a short-term or long-term treatment according to guidelines?
A: Citao is indicated for both the acute (short-term) and maintenance (long-term) treatment of Major Depressive Disorder. The drug is designed for both short and sustained use, but the long-term usefulness is subject to periodic re-evaluation.
